Jakson kuvaus
CMS has finalized the GLOBE Model, introducing international drug pricing benchmarks for select Medicare Part B drugs. But the final rule looks significantly different from the original proposal.
In this episode of Revenue RX, Lubna Mazin breaks down what changed, how reduced patient coinsurance affects provider reimbursement, and what pharmacy revenue cycle, finance, and patient financial services teams need to know before implementation begins in 2027.
Takeaways
• GLOBE is a mandatory five-year Medicare Part B model using international pricing benchmarks to calculate manufacturer…

